Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Arif AKYILDIZ"'
Autor:
Fatih Kus MD, Deniz Can Guven PhD, Hasan Cagri Yildirim PhD, Baran Akagunduz PhD, Serdar Karakaya PhD, Osman Sutcuoglu PhD, Elvin Chalabiyev MD, Arif Akyildiz MD, Baris Koksal MD, Yigit Berk Sahin MD, Ece Karaca MD, Oguz Alp Kavruk MD, Nefise Tugce Zor MD, Firat Sirvan MD, Ozan Yazici PhD, Suayib Yalcin PhD
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Aims: This study aimed to assess the habits and knowledge of cancer patients regarding the use of herbal medicines and dietary supplements in cancer patients receiving immune checkpoint inhibitors (ICI). Methods: The data of 181 cancer patients who w
Externí odkaz:
https://doaj.org/article/171b5c2135e74f2db40143086b69d588
Autor:
Hasan Cagri Yildirim, Hicran Anik, Deniz Ates Ozdemir, Rashad Ismayilov, Arif Akyildiz, Kerim Cayiroz, Fahri Ceyhan, Oguzalp Kavruk, Deniz Can Guven, Ozturk Ates, Alp Usubutun, Zafer Arik
Publikováno v:
Biomolecules & Biomedicine (2024)
This study addresses the gap in understanding the prognostic relevance of hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression in metastatic cervical squamous cell carcinoma (SCC) patients undergoing anti-vascular endothelial growth factor-based
Externí odkaz:
https://doaj.org/article/0a6679b01dca4c8a82ddcef55b98579d
Autor:
Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 824 (2024)
Trastuzumab emtansine (T-DM1) is a mainstay therapy for HER2-positive metastatic breast cancer (mBC). However, identifying patients who will benefit most remains a challenge due to the lack of reliable biomarkers. The recently developed pan-immune-in
Externí odkaz:
https://doaj.org/article/cba09664a7234950a7696ece067a4ea8
Autor:
Safak Mirioglu, Yasar Caliskan, Yasemin Ozluk, Ahmet Burak Dirim, Zulal Istemihan, Arif Akyildiz, Halil Yazici, Aydin Turkmen, Isin Kilicaslan, Mehmet Sukru Sever
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-12 (2019)
Background/Aims: We aimed to investigate the effects of glomerular IgM and C3 deposition on outcomes of adult patients with primary focal segmental glomerulosclerosis (FSGS). Methods: In this retrospective analysis, 86 consecutive adult patients with
Externí odkaz:
https://doaj.org/article/9a346a51ebc64300994169ab799ec0c4
Autor:
Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktas, Suayib Yalcin, Omer Dizdar
Publikováno v:
Expert Review of Anticancer Therapy. 23:243-256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e593a57d28a53b432f8f1f51eab9f515
https://doi.org/10.1080/14737140.2023.2183844
https://doi.org/10.1080/14737140.2023.2183844
Autor:
Hasan Çağrı YILDIRIM, Meral ÜNER, Tuğba YILDIRAN ÖZMEN, Elvin CHALABIYEV, Deniz Can GÜVEN, Fatih KUŞ, Arif AKYILDIZ, Feride YILMAZ, Serkan YAŞAR, Yasemin EVLENDİ, Ömer DİZDAR, Şuayib YALÇIN, Ayşegül ÜNER, Sercan AKSOY
Publikováno v:
Journal of Oncological Sciences. 9:33-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::366f2b86f37b1cff9237d72e86da112e
https://doi.org/10.37047/jos.2022-94227
https://doi.org/10.37047/jos.2022-94227
Autor:
Hasan Cagri Yildirim, Arif Akyildiz, Rashad Ismayilov, Nartan Demirok, Burhan Sami Benli, Deniz Can Guven, Serkan Akin, Suayib Yalcin, Ibrahim Barista
Publikováno v:
memo - Magazine of European Medical Oncology. 15:307-310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b0b96e7c1d09bd943ef758be2e8c894
https://doi.org/10.1007/s12254-022-00843-4
https://doi.org/10.1007/s12254-022-00843-4
Autor:
Elvin Chalabiyev, Safa can Efil, Deniz Can Guven, Hasan Cagri Yildirim, Arif Akyildiz, Fatih Kus, Rashad Ismayilov, Omer Dizdar, Suayib Yalcin, Omer Denizhan Tatar
Background The prognostic nutritional index (PNI), estimated using serum albumin concentration and peripheral blood cell count, is a promising predictor of outcomes in patients with colon cancer. We aimed to show the difference in survival times base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4119f45c74e797388e13f018673551d8
https://doi.org/10.21203/rs.3.rs-2786751/v1
https://doi.org/10.21203/rs.3.rs-2786751/v1
Autor:
Feride Yılmaz, Serkan Yaşar, Ömer Denizhan Tatar, Hasan Çağrı Yıldırım, Deniz Can Güven, Arif Akyıldız, Elvin Chalabiyev, Burak Yasin Aktaş, Zafer Arık, Mustafa Erman
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Despite initial dramatic responses, metastatic small cell lung cancer (SCLC) invariably recurs. Irinotecan is one of the active agents for patients with recurrent SCLC. In the second line, weekly or three-weekly irinotecan regimen
Externí odkaz:
https://doaj.org/article/d05ee6cbcd604c23bdd7f7e674ff535f
Autor:
Hasan Çağrı YILDIRIM, Deniz Can GÜVEN, Elvin CHALABIYEV, Hakan TABAN, Feride YILMAZ, Serkan YAŞAR, Fatih KUŞ, Arif AKYILDIZ, Süleyman Çağın GÜRBÜZ, Hüseyin SAYIN, Gözde KAVGACI, Şuayib YALÇIN, Ömer DİZDAR
Publikováno v:
Journal of Oncological Sciences. 8:143-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9050e71245d8c1d1cb07bf54d3e1f4be
https://doi.org/10.37047/jos.2022-92230
https://doi.org/10.37047/jos.2022-92230